摘要 |
The present invention relates to novel compounds, termed serpentemycins, of the formula (I) in which Y, R, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, X, X<SUB>2</SUB>, X<SUB>3</SUB>, n, m and o are as defined in the specification, which are formed by the microorganism Actinomycetales sp. DSM 14865 during its fermentation, to chemical derivatives of the serpentemycins, to a process for preparing them, and to their use as pharmaceuticals, in particular for the treatment and prophylaxis of infectious bacterial diseases.
|